[Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
Hafner
C
C
Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg. christian.hafner@klinik.uni-regensburg.de
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016503:Drug Delivery Systems / Q000379:methods*; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D015398:Signal Transduction / Q000187:drug effects*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D000970:Antineoplastic Agents; D053823:Hedgehog Proteins
Zielgerichtete medikamentöse Therapie des Basalzellkarzinoms durch Inhibition des Hedgehog-Signalwegs.